ArticleJournal of clinical medicine2020

Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation.

Sang Jin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.